Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial.
Katharina Schmalstieg-BahrDavid J GladstoneEva HummersJohanna SuerbaumJeffrey S HealeyAntonia ZapfDenise KösterStefanie M WerhahnRolf WachterPublished in: The European journal of general practice (2024)
Natriuretic peptide levels and hsTnI are higher in patients with AF than without and may help select patients for AF screening, but larger trials are needed.
Keyphrases
- atrial fibrillation
- clinical trial
- end stage renal disease
- catheter ablation
- oral anticoagulants
- newly diagnosed
- ejection fraction
- study protocol
- left atrial
- left atrial appendage
- heart failure
- direct oral anticoagulants
- peritoneal dialysis
- open label
- randomized controlled trial
- patient reported outcomes
- phase iii
- coronary artery disease
- venous thromboembolism
- placebo controlled